(Q37030940)

17 August 2017

Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan (English)

1 reference

17 August 2017

1 reference

2

Ellen Wright Clayton

0 references

author name string

Iekuni Ichikawa

series ordinal

1

1 reference

PMC publication ID

4917904

17 August 2017

Ellen Wright Clayton

series ordinal

2

1 reference

17 August 2017

1 February 2016

1 reference

Accountability in Research

17 August 2017

1 reference

17 August 2017

23

1 reference

17 August 2017

4

1 reference

17 August 2017

245-253

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

17 August 2017

start time

1 February 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4917904

Industry sponsorship and research outcome: a Cochrane review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4917904

Pharmaceutical industry marketing: understanding its impact on women's health

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4917904

Evaluation of conflict of interest in economic analyses of new drugs used in oncology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4917904

Retraction--Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4917904

Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4917904

Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4917904

Impact of renin-angiotensin system inhibition on microalbuminuria in type 2 diabetes: a post hoc analysis of the Shiga Microalbuminuria Reduction Trial (SMART).

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4917904

Concerns about the Jikei Heart Study

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26829657

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Retraction--Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26829657

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Retraction of: Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study [Eur Heart J (2009) 30:2461-2469, doi: 10.1093/eurheartj/ehp363]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26829657

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/S0140-6736(07)60669-2

Identifiers

DOI

10.1080/08989621.2016.1144478

1 reference

17 August 2017

1 reference

PMC publication ID

4917904

17 August 2017

PubMed publication ID

26829657

1 reference

PMC publication ID

4917904